Abstract: This invention relates to therapeutic infusion assemblies, more specifically a device for the subcutaneous delivery of a fluid from a remote source. Applicant provides a base assembly which has a fluid channel therein and a cannula extending vertically downward from a flat bottom. A fluid connector member which receives a fluid bearing line from the remote fluid source and the fluid connector member pivotably and removably connects to the base member. The manner of connection is “hinged” allowing the fluid connector to move from a non-use position by rotation downward to a used position. In the use position a fluid channel in the fluid connector will connect with a fluid channel in the base to provide fluid to the cannula and to the patient.

Abstract: A magnetic shield having non-magnetic gaps provides reduced magnetic cross-talk for a linear motor array in a precision positioning system. Redirecting the leakage flux limits the cross-talk and associated deleterious effects. Such preferred magnetic circuit paths for the leakage are affixed to the moving magnet system of the linear motor. Embodiments of the preferred flux leakage paths are realized by providing a ferromagnetic shield separated by a non-magnetic gap between the permanent magnets and the back-irons. In another embodiment, the ferromagnetic shield separation includes diamagnetic materials.

Abstract: A hybrid supercapacitor comprises a double layer electrode and a redox electrode, in which the ratio of the volumes, and hence the thicknesses, of the two electrodes is significantly higher than previously considered optimum, specifically from 9:1 to 100:1.

Abstract: An electrochemical cell for a smart is compressible under a pressure not exceeding 4.5 MegaPascal to reduce reversibly its thickness by at least 5% and has at least two external surfaces (3, 4), electrically insulated from each other, which are electrically conducting and are, or are in electrical contact with, respective electrodes (1, 2).

Abstract: An apparatus, system, and method are disclosed for copying data. The present invention includes a data storage subsystem that supports fast replication and a host system that communicates a fast replication request to the data storage subsystem, estimates an expected wait time for a pending fast replication operation if the fast replication request is not granted, awaits the expiration of the wait time, communicates an additional fast replication request to the data storage subsystem, and records the data as moved if the additional fast replication is granted. In certain embodiments, the host system moves the data via conventional I/O operations if the expected wait time exceeds an expected duration for the conventional I/O operations.

Abstract: An IP bridge phone for operatively coupling one or more analog phones to a digital communications network to support parallel communications is disclosed. The IP bridge phone includes a phone handset interface adapted to connect to a phone handset, an analog phone interface, and a network interface. A mixing module is adapted to receive a first voice signal from the handset interface, a second voice signal from the analog phone, and a third voice signal from the data communications network; generate a plurality of combined signals from the first voice signal, the second voice signal, and the third voice signal; and transmit each of the plurality of combined signals to one of the plurality of interfaces. The plurality of combined signals provide parallel communications between the phone handset, the analog phone, and the remote calling party.

Abstract: System for the subcutaneous delivery into the body of a patient of a fluid from a remote vessel. The system includes a main assembly and placement member with a needle. A delivery tube for carrying the fluid is attached at a near end to the remote reservoir or vessel. At removed end, the delivery tube has a needle for engagement with the main assembly. The main assembly includes a rotating member that when the rotating is perpendicular to the main assembly, it will accept the handle and needle for emplacement of the body onto a patient. After the handle and needle are removed, the delivery tube can be attached to the rotating member which can then be rotated down to a position along to and adjacent the skin of the patient. This provides for a flush mounted infusion device.

Abstract: System for the subcutaneous delivery into the body of a patient of a fluid from a remote vessel. The system includes a main assembly and placement member with a needle. A delivery tube for carrying the fluid is attached at a near end to the remote reservoir or vessel. At removed end, the delivery tube has a needle for engagement with the main assembly. The main assembly includes a rotating member that when the rotating is perpendicular to the main assembly, it will accept the handle and needle for emplacement of the body onto a patient. After the handle and needle are removed, the delivery tube can be attached to the rotating member which can then be rotated down to a position along to and adjacent the skin of the patient. This provides for a flush mounted infusion device.

Abstract: A universal strut clamping device preferably made from steel components and is utilized as a load bearing support for conduits and the like. This clamping device, which is always used in pairs, is comprised of a single baseplate with an attached strut locating guide and further including an aperture for a longitudinally installed threaded rod which will be used to attach to a building member and further compress a preformed metallic strut between each clamping device. The versatility of this support allows the installer the options of attaching the strut bracket rigidly to a wall, floor or ceiling in a cantilever configuration, or suspending it from a building structure by a single threaded rod as a vertical trapeze.

Abstract: An IP telephone appliance providing secure voice communication and data transmission for itself and other IP devices and applications associated with it. The IP telephone appliance incorporates a processor for converting voice signals received from a user into VoIP packets, and an IPSec stack encoding packets prior to transmission. The IP telephone appliance also encodes packets on behalf of other devices and applications prior to transmitting the packets to a destination. When encoded voice or data packets are received from a source device, the IP telephone appliance decodes the packets and determines their destination. If the IP telephone appliance is the ultimate destination, the voice/data packets are converted to voice/telephony signals and provided to the user. Otherwise, if the ultimate destination is another device on the network, the IP telephone appliance forwards the decoded packets to the ultimate destination.

Abstract: A nanoporous filter comprises a porous support having an essentially flat surface on which is deposited a nanoporous layer having a substantially regular pore structure and uniform pore size within the range from 1 to 50 nm.

Abstract: An apparatus, system, and method are disclosed for copying data. The present invention includes a data storage subsystem that supports fast replication and a host system that communicates a fast replication request to the data storage subsystem, estimates an expected wait time for a pending fast replication operation if the fast replication request is not granted, awaits the expiration of the wait time, communicates an additional fast replication request to the data storage subsystem, and records the data as moved if the additional fast replication is granted. In certain embodiments, the host system moves the data via conventional I/O operations if the expected wait time exceeds an expected duration for the conventional I/O operations.

Abstract: Novel polypeptide combinations, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for soluble zalpha11 receptors that may be used as novel cytokine antagonists, and within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block zalpha11 Ligand activity in vitro and in vivo, and may be used in conjunction with zalpha11 Ligand and other cytokines to selectively stimulate the immune system. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.

Abstract: This invention relates to therapeutic infusion assemblies, more specifically a device for the subcutaneous delivery of a fluid from a remote source. Applicant provides a base assembly which has a fluid channel therein and a cannula extending vertically downward from a flat bottom. A fluid connector member which receives a fluid bearing line from the remote fluid source and the fluid connector member pivotably and removably connects to the base member. The manner of connection is “hinged” allowing the fluid connector to move from a non-use position by rotation downward to a used position. In the use position a fluid channel in the fluid connector will connect with a fluid channel in the base to provide fluid to the cannula and to the patient.

Abstract: Antibodies that bind to polypeptides and peptides comprising the sequence of zalpha11 Ligand as shown in SEQ ID NO: 2 are described. The antibodies may bind the full length sequence of 162 amino acid residues or a fragment thereof, including a mature polypeptide of 131 amino acid residues and smaller polypeptide and peptide sequences. The antibodies may include antibodies that are polyclonal, monoclonal, murine, humanized or neutralizing. Methods for producing the antibodies are also described.

Abstract: Methods for treating mammals with cancer using molecules that have an IL-21 functional activity are described. The molecules having IL-21 functional activities include polypeptides that have homology to the human IL-21 polypeptide sequence and proteins fused to a polypeptide with IL-21 functional activity. The molecules can be used as a monotherapy or in combination with other known cancer therapeutics.

Abstract: This invention relates to therapeutic infusion assemblies, more specifically a device for the subcutaneous delivery of a fluid from a remote source. Applicant provides a base assembly which has a fluid channel therein and a cannula extending vertically downward from a flat bottom. A fluid connector member which receives a fluid bearing line from the remote fluid source and the fluid connector member pivotably and removably connects to the base member. The manner of connection is “hinged” allowing the fluid connector to move from a non-use position by rotation downward to a used position. In the use position a fluid channel in the fluid connector will connect with a fluid channel in the base to provide fluid to the cannula and to the patient.

Abstract: Antibodies that bind to polypeptides and peptides comprising the sequence of zalpha11 Ligand as shown in SEQ ID NO: 2 are described. The antibodies may bind the full length sequence of 162 amino acid residues or a fragment thereof, including a mature polypeptide of 131 amino acid residues and smaller polypeptide and peptide sequences. The antibodies may include antibodies that are polyclonal, monoclonal, murine, humanized or neutralizing. Methods for producing the antibodies are also described.

Abstract: Antibodies that bind to polypeptides and peptides comprising the sequence of zalpha11 Ligand as shown in SEQ ID NO: 2 are described. The antibodies may bind the full length sequence of 162 amino acid residues or a fragment thereof, including a mature polypeptide of 131 amino acid residues and smaller polypeptide and peptide sequences. The antibodies may include antibodies that are polyclonal, monoclonal, murine, humanized or neutralizing. Methods for producing the antibodies are also described.

Abstract: Antibodies that bind to polypeptides and peptides comprising the sequence of zalpha11 Ligand as shown in SEQ ID NO: 2 are described. The antibodies may bind the full length sequence of 162 amino acid residues or a fragment thereof, including a mature polypeptide of 131 amino acid residues and smaller polypeptide and peptide sequences. The antibodies may include antibodies that are polyclonal, monoclonal, murine, humanized or neutralizing. Methods for producing the antibodies are also described.